Clinical Trials Browser

Phase 2 × Graft vs Host Disease × Fibroblast Growth Factor 7 × Clear all

NCT00189488 2014-09-15

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Phase 2 Completed

155 enrolled 19 charts

Other hematologic neoplasm

Graft vs Host Disease, Stomatitis, Hematologic Neoplasms